Catherine Chapelon-Abric Selected Research

Catherine Chapelon-Abric Research Topics

17	Sarcoidosis (Schaumann Disease) 01/2022 - 02/2006
2	Neurosarcoidosis 01/2023 - 01/2022
1	Hypertension (High Blood Pressure) 01/2020
1	Atrioventricular Block 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Uveitis 01/2017
1	Tuberculosis (Tuberculoses) 09/2011
1	Spondylarthritis (Spinal Arthritis) 09/2011
1	Myositis (Idiopathic Inflammatory Myopathies) 06/2011
1	Inclusion Body Myositis 06/2011
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 03/2010
1	Spinal Cord Diseases 03/2010
1	Infections 02/2009
1	Inflammation (Inflammations) 02/2006
1	Granuloma 02/2006

4	AntigensIBA 01/2022 - 02/2006
3	SteroidsIBA 03/2018 - 06/2011
3	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 02/2009
3	Infliximab (Remicade)FDA Link 10/2017 - 07/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 11/2019
2	CytokinesIBA 01/2018 - 02/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	MineralsIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2022
1	GadoliniumIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2019
1	GlucocorticoidsIBA 11/2019
1	Adalimumab (Humira)FDA Link 01/2017
1	Dipyridamole (Persantine)FDA LinkGeneric 06/2012
1	ThalliumIBA 06/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2010
1	C-Reactive ProteinIBA 03/2010
1	Proteins (Proteins, Gene)FDA Link 03/2010

4	Therapeutics 01/2022 - 06/2012
1	Off-Label Use 10/2017